EyePoint Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release…

Biotechnology
US, Watertown [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

EyePoint Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

EyePoint Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of EyePoint Pharmaceuticals, Inc..

End of EYPT's Analysis
CIK: 1314102 CUSIP: 30233G209 ISIN: US30233G2093 LEI: - UEI: -
Secondary Listings
EYPT has no secondary listings inside our databases.